<DOC>
	<DOCNO>NCT01446601</DOCNO>
	<brief_summary>The purpose study evaluate benefit risk hypoglossal nerve stimulation Apnex Medical Hypoglossal Nerve Stimulation ( HGNS ) System potential therapeutic option individual moderate severe Obstructive Sleep Apnea ( OSA ) fail tolerate positive airway pressure ( PAP ) therapy .</brief_summary>
	<brief_title>Apnex Clinical Study Hypoglossal Nerve Stimulation ( HGNS® ) System Treat Obstructive Sleep Apnea</brief_title>
	<detailed_description />
	<mesh_term>Apnea</mesh_term>
	<mesh_term>Sleep Apnea Syndromes</mesh_term>
	<mesh_term>Sleep Apnea , Obstructive</mesh_term>
	<criteria>Age 21 80 year Body mass index ( BMI ) ≤ 35 kg/m² Previously diagnose Moderate severe OSA Individual fail tolerate PAP therapy</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>December 2011</verification_date>
	<keyword>Apnea</keyword>
	<keyword>OSA</keyword>
	<keyword>Sleep Apnea Syndromes</keyword>
	<keyword>Sleep Apnea , Obstructive</keyword>
	<keyword>Hypoglossal Nerve Stimulation</keyword>
	<keyword>Sleep Disorders</keyword>
	<keyword>Tongue</keyword>
</DOC>